Food and Drug Administration

Nonprescription Drugs Advisory Committee and the Advisory Committee for Reproductive Health Drugs

December 16, 2003


Plan B®, Dr. Curtis Rosebraugh, MD, MPH, FDA (HTM) (PPT)

Plan B® (Levonorgestrel) For Emergency Contraception Rx-to-OTC Switch, Dr. Carole Ben-Maimon, MD, on behalf of Women's Capital Corp. (HTM) (PPT)

Safety Review for Plan B, Dr. Daniel Davis, MD, MPH, FDA (HTM) (PPT)

Plan B - Label Comprehension Study, Dr. Karen Lechter, JD, PhD, FDA (HTM) (PPT)

Plan B® Actual Use and Behavior Studies, NDA 21-045, Dr. Jin Chen, MD, PhD, FDA (HTM) (PPT)

Open Public Hearing

Open Public Hearing Speakers List (HTM) (PPT)

The Effects of Advance Provision of Emergency Contraception on Adolescent Women's Sexual and Contraceptive Behaviors, Dr. Melanie Gold, DO, et. al. (HTM) (PPT)

Presentation by Jill Stanek, Concerned Women for America (HTM) (PPT)